Gene · 8038
Papers1,979
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,979
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current Concepts on the Pathogenesis of Systemic Sclerosis. | Clin Rev Allergy Immunol | 2023 | 34487318 | PubTator, text mining | PubMed |
| The Cancer-Associated Fibroblasts-Related Gene COMP Is a Novel Predictor for Prognosis and Immunotherapy Efficacy and Is Correlated with M2 Macrophage Infiltration in Colon Cancer. | Biomolecules | 2022 | 36671447 | PubTator, text mining | PubMed |
| Genome-wide association study for vascular aging highlights pathways shared with cardiovascular traits in Koreans. | Front Cardiovasc Med | 2022 | 36620623 | PubTator, text mining | PubMed |
| Invadosome Formation by Lung Fibroblasts in Idiopathic Pulmonary Fibrosis. | Int J Mol Sci | 2022 | 36613948 | PubTator, text mining | PubMed |
| Essential Role of Multi-Omics Approaches in the Study of Retinal Vascular Diseases. | Cells | 2022 | 36611897 | PubTator, text mining | PubMed |
| Extracellular Events Involved in Cancer Cell-Cell Fusion. | Int J Mol Sci | 2022 | 36555709 | PubTator, text mining | PubMed |
| MicroRNA-149 Regulates Proliferation, Migration, and Invasion of Pituitary Adenoma Cells by Targeting ADAM12 and MMP14. | Curr Med Sci | 2022 | 36542326 | PubTator, text mining | PubMed |
| Single-cell multiomics revealed the dynamics of antigen presentation, immune response and T cell activation in the COVID-19 positive and recovered individuals. | Front Immunol | 2022 | 36532041 | PubTator, text mining | PubMed |
| Weighted gene co-expression network reveals driver genes contributing to phenotypes of anaplastic thyroid carcinoma and immune checkpoint identification for therapeutic targets. | Front Oncol | 2022 | 36530988 | PubTator, text mining | PubMed |
| Effects of Subtoxic Concentrations of Atrazine, Cypermethrin, and Vinclozolin on microRNA-Mediated PI3K/Akt/mTOR Signaling in SH-SY5Y Cells. | Int J Mol Sci | 2022 | 36498866 | PubTator, text mining | PubMed |
| Fibroblast inflammatory priming determines regenerative versus fibrotic skin repair in reindeer. | Cell | 2022 | 36493752 | PubTator, text mining | PubMed |
| Single-Cell Sequencing in Rheumatic Diseases: New Insights from the Perspective of the Cell Type. | Aging Dis | 2022 | 36465169 | PubTator, text mining | PubMed |
| Identification of microRNA editing sites in three subtypes of leukemia. | Front Mol Biosci | 2022 | 36452459 | PubTator, text mining | PubMed |
| Investigating isoform switching in RHBDF2 and its role in neoplastic growth in breast cancer. | PeerJ | 2022 | 36452073 | PubTator, text mining | PubMed |
| Myofibroblast specific targeting approaches to improve fibrosis treatment. | Chem Commun (Camb) | 2022 | 36445310 | PubTator, text mining | PubMed |
| The multifaceted role of GCM1 during trophoblast differentiation in the human placenta. | Proc Natl Acad Sci U S A | 2022 | 36442132 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Players in the Anti-Inflammatory Inter-Cellular Crosstalk Induced by Exercise Training. | Int J Mol Sci | 2022 | 36430575 | PubTator, text mining | PubMed |
| Spontaneous Transformation of a p53 and Rb-Defective Human Fallopian Tube Epithelial Cell Line after Long Passage with Features of High-Grade Serous Carcinoma. | Int J Mol Sci | 2022 | 36430324 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis Identifies Tumor Cell Surface Targets for CAR-T Cell Therapies and Antibody Drug Conjugates. | Cancers (Basel) | 2022 | 36428765 | PubTator, text mining | PubMed |
| Identification of Factors Driving Doxorubicin-Resistant Ewing Tumor Cells to Survival. | Cancers (Basel) | 2022 | 36428591 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8038/papers?page=15